Insulin Aspart
Yes
Yes
Medical Assistance Fund
Standard Drug List
Active ingredient: Insulin Aspart
General information
Subsidy Information and Financing Scheme
[SDL] Insulin Aspart (Novorapid) Injection, Prefilled Pen 100 international units/mL
[MAF] Insulin Aspart (Novorapid) Injection, Penfill 100 international units/mL
Type 1 & 2 diabetes mellitus
Drug Guidance for Subsidy
02/01/2024 Insulin aspart (Fiasp) for treating diabetes mellitus
[NR] The Ministry of Health’s Drug Advisory Committee has not recommended insulin aspart (Fiasp) for inclusion on the MOH List of Subsidised Drugs for treating diabetes mellitus due to limited clinical need and unfavourable cost effectiveness compared with alternative treatments.
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Novorapid Injection, Prefilled Pen 100 international units/mL |
|
Novorapid Injection, Penfill 100 international units/mL |
|
List of monographs containing this active ingredient
Insulin Aspart + Insulin Aspart Protamine [Novomix]
Insulin Aspart + Insulin Aspart Protamine #
